Prescription drug use in pregnancy.

Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42

Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol (2015) 2.17

A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry (2013) 2.12

The second wave: Toward responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth (2008) 2.07

Underuse of pregnancy testing for women prescribed teratogenic medications in the emergency department. Acad Emerg Med (2015) 1.96

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations. PLoS One (2013) 1.74

Counseling about medication-induced birth defects with clinical decision support in primary care. J Womens Health (Larchmt) (2013) 1.60

Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol (2011) 1.49

Prevalence and patterns of antidepressant drug use during pregnancy. Eur J Clin Pharmacol (2006) 1.43

Antiepileptic drug use by pregnant women enrolled in Florida Medicaid. Neurology (2015) 1.41

Characteristics and publication patterns of obstetric studies registered in ClinicalTrials.gov. J Clin Pharmacol (2013) 1.40

Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women. Ann Intern Med (2007) 1.35

Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiol Drug Saf (2011) 1.32

Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos (2013) 1.27

Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States. Anesthesiology (2014) 1.24

Isoform-specific regulation of cytochromes P450 expression by estradiol and progesterone. Drug Metab Dispos (2012) 1.24

Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol (2008) 1.19

Women's perspectives on counseling about risks for medication-induced birth defects. Birth Defects Res A Clin Mol Teratol (2010) 1.17

BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm Res (2008) 1.17

We don't know what we don't study: the case for research on medication effects in pregnancy. Am J Med Genet C Semin Med Genet (2011) 1.16

Perspectives of primary care clinicians on teratogenic risk counseling. Birth Defects Res A Clin Mol Teratol (2009) 1.14

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf (2010) 1.12

Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med (2010) 1.11

Randomized trial to improve prescribing safety during pregnancy. J Am Med Inform Assoc (2007) 1.10

FDA's proposed rule for pregnancy and lactation labeling: improving maternal child health through well-informed medicine use. J Med Toxicol (2008) 1.09

The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol (2015) 1.09

Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database. Eur J Clin Pharmacol (2009) 1.08

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics. Br J Clin Pharmacol (2012) 1.07

Counseling of female veterans about risks of medication-induced birth defects. J Gen Intern Med (2013) 1.05

Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int J Obes (Lond) (2013) 1.05

Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol (2011) 1.04

Antidepressant use during pregnancy: current controversies and treatment strategies. Clin Obstet Gynecol (2009) 1.03

Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opin Drug Metab Toxicol (2010) 1.02

A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction. CPT Pharmacometrics Syst Pharmacol (2012) 1.02

Drug use in pregnancy; a point to ponder! Indian J Pharm Sci (2009) 1.01

ATP-binding cassette efflux transporters in human placenta. Curr Pharm Biotechnol (2011) 0.98

Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol (2009) 0.98

A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure. J Clin Psychiatry (2011) 0.98

Estradiol induces cytochrome P450 2B6 expression at high concentrations: implication in estrogen-mediated gene regulation in pregnancy. Biochem Pharmacol (2012) 0.98

Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice. J Biol Chem (2013) 0.97

Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network. PLoS One (2015) 0.92

Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark. Clin Epidemiol (2011) 0.92

Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Matern Child Health J (2006) 0.91

Clinical decision support to promote safe prescribing to women of reproductive age: a cluster-randomized trial. J Gen Intern Med (2012) 0.91

The ethics and regulatory landscape of including vulnerable populations in pragmatic clinical trials. Clin Trials (2015) 0.90

Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review. Eur Child Adolesc Psychiatry (2014) 0.89

Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006. Matern Child Health J (2015) 0.89

The National Children's Study: a golden opportunity to advance the health of pregnant women. Am J Public Health (2009) 0.88

Clinical research enrolling pregnant women: a workshop summary. J Womens Health (Larchmt) (2011) 0.88

Detecting pregnancy use of non-hormonal category X medications in electronic medical records. J Am Med Inform Assoc (2011) 0.87

Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol (2009) 0.87

Prescription drug use during and immediately before pregnancy in Hawai'i—findings from the Hawai'i Pregnancy Risk Assessment Monitoring System, 2009-2011. Hawaii J Med Public Health (2014) 0.87

Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol (2013) 0.87

The rights and wrongs of blood-brain barrier permeability studies: a walk through 100 years of history. Front Neurosci (2014) 0.87

Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Br J Clin Pharmacol (2012) 0.86

Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf (2013) 0.85

Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy. Drug Metab Dispos (2012) 0.85

Designing drug trials: considerations for pregnant women. Clin Infect Dis (2014) 0.85

Isoform-specific regulation of cytochrome P450 expression and activity by estradiol in female rats. Biochem Pharmacol (2011) 0.84

Rhinologic issues in pregnancy. Allergy Rhinol (Providence) (2012) 0.83

Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS One (2013) 0.83

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review. PLoS Med (2016) 0.83

Pro-inflammatory cytokine regulation of P-glycoprotein in the developing blood-brain barrier. PLoS One (2012) 0.83

Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template. J Womens Health (Larchmt) (2013) 0.82

Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J (2013) 0.82

Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study. PLoS One (2015) 0.82

Drugs in pregnancy: Implications for a cardiologist. Exp Clin Cardiol (2010) 0.82

Promoting safe prescribing in primary care with a contraceptive vital sign: a cluster-randomized controlled trial. Ann Fam Med (2012) 0.81

Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age. Antimicrob Agents Chemother (2011) 0.81

Self-organizing human cardiac microchambers mediated by geometric confinement. Nat Commun (2015) 0.81

Challenges in Studying Modifiable Risk Factors for Birth Defects. Curr Epidemiol Rep (2015) 0.80

P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study. Drug Saf (2015) 0.80

Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci (2011) 0.80

Lessons learned in pediatric clinical research to evaluate safe and effective use of drugs in pregnancy. Obstet Gynecol (2015) 0.79

Corticosteroid use and risk of orofacial clefts. Birth Defects Res A Clin Mol Teratol (2014) 0.79

Prenatal antidepressant exposure: clinical and preclinical findings. Pharmacol Rev (2014) 0.79

Exposure of drugs for hypertension, diabetes, and autoimmune disease during pregnancy and perinatal outcomes: an investigation of the regulator in Japan. Medicine (Baltimore) (2015) 0.78

Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. Antimicrob Agents Chemother (2014) 0.78

Epidemiology of medications use in pregnancy. Semin Perinatol (2015) 0.78

Use of medicines with unknown fetal risk among parturient women from the 2004 Pelotas Birth Cohort (Brazil). J Pregnancy (2012) 0.77

Pregnant womens' concerns when invited to a randomized trial: a qualitative case control study. BMC Pregnancy Childbirth (2015) 0.77

The multidrug resistance 1 gene Abcb1 in brain and placenta: comparative analysis in human and guinea pig. PLoS One (2014) 0.77

Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies. Pharmacoepidemiol Drug Saf (2015) 0.77

Neonatal pharmacology: rational therapeutics for the most vulnerable. Clin Pharmacol Ther (2009) 0.77

Quality of medical care in diabetic women undergoing fertility treatment: we should do better! Diabetes Care (2011) 0.77

Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. Eur J Clin Pharmacol (2014) 0.77

Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age. Eur J Clin Pharmacol (2014) 0.76

Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol (2016) 0.76

Clinical correlates of prescription opioid analgesic use in pregnancy. Matern Child Health J (2015) 0.76

Effect of pregnancy on nitrofurantoin disposition in mice. J Pharm Sci (2009) 0.75

Drug use during early pregnancy: cross-sectional analysis from the Childbirth and Health Study in Primary Care in Iceland. Scand J Prim Health Care (2014) 0.75

Regulation of Drug Disposition Gene Expression in Pregnant Mice with Car Receptor Activation. Nucl Receptor Res (2016) 0.75

Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth (2015) 0.75

Awareness of Mothers and Doctors about Drug Utilization Pattern for Illnesses Encountered during Pregnancy. J Clin Diagn Res (2013) 0.75

New retrospective analysis of drugs gives pregnant pause. Nat Med (2010) 0.75

Astrocyte-mediated regulation of multidrug resistance p-glycoprotein in fetal and neonatal brain endothelial cells: age-dependent effects. Physiol Rep (2016) 0.75

Pharmacogenetics and individualizing drug treatment during pregnancy. Pharmacogenomics (2014) 0.75

Pain Management in Pregnancy: Multimodal Approaches. Pain Res Treat (2015) 0.75

The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update. J Womens Health (Larchmt) (2016) 0.75

Drug therapy during pregnancy: implications for dental practice. Br Dent J (2016) 0.75

Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20

The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19

The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr (2013) 6.18

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA (2004) 5.25

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25

Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf (2006) 5.16

Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74

Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71

Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother (2006) 4.28

Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med (2012) 4.19

Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16

Design of a national distributed health data network. Ann Intern Med (2009) 4.09

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? J Natl Cancer Inst (2004) 3.86

Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med (2010) 3.83

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology (2008) 3.79

Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerg Infect Dis (2002) 3.79

A generalized linear mixed models approach for detecting incident clusters of disease in small areas, with an application to biological terrorism. Am J Epidemiol (2004) 3.71

Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med (2007) 3.71

Health plan members' views about disclosure of medical errors. Ann Intern Med (2004) 3.69

Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics (2006) 3.61

Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42

Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics (2005) 3.42

Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med (2007) 3.34

Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics (2009) 3.32

Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30

Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care (2010) 3.29

Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis (2003) 3.24

Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA (2006) 3.20

ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12

Outcomes of prenatal antidepressant exposure. Am J Psychiatry (2002) 3.07

Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol (2007) 3.06

Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med (2008) 3.06

Developing the Sentinel System--a national resource for evidence development. N Engl J Med (2011) 2.93

A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care (2012) 2.92

Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst (2005) 2.86

Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy (2008) 2.82

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73

The new Sentinel Network--improving the evidence of medical-product safety. N Engl J Med (2009) 2.73

Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus. Hepatology (2012) 2.63

Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet (2013) 2.63

Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol (2007) 2.61

The risk of hospitalized infection in patients with rheumatoid arthritis. J Rheumatol (2008) 2.60

Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 2.57

Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics (2002) 2.54

Unexplained variation across US nursing homes in antipsychotic prescribing rates. Arch Intern Med (2010) 2.51

The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med (2008) 2.46

Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis (2003) 2.45

Automated identification of acute hepatitis B using electronic medical record data to facilitate public health surveillance. PLoS One (2008) 2.45

Electronic Support for Public Health: validated case finding and reporting for notifiable diseases using electronic medical data. J Am Med Inform Assoc (2008) 2.44

Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ (2005) 2.43

Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf (2012) 2.41

Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med (2014) 2.41

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile. Pharmacoepidemiol Drug Saf (2006) 2.38

Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J Infect Dis (2009) 2.36

Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care (2005) 2.33

A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33

Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33

Is size the next big thing in epidemiology? Epidemiology (2013) 2.31

Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30

Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29

Multivariate scan statistics for disease surveillance. Stat Med (2007) 2.27

Effect of New York State regulatory action on benzodiazepine prescribing and hip fracture rates. Ann Intern Med (2007) 2.27

Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21

Potential medication dosing errors in outpatient pediatrics. J Pediatr (2005) 2.19

Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19

Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol (2013) 2.17

Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med (2006) 2.17

Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med (2012) 2.17

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. Arthritis Rheum (2007) 2.16

Effect of a pediatric hospitalist system on housestaff education and experience. Arch Pediatr Adolesc Med (2002) 2.15

How to design computerized alerts to safe prescribing practices. Jt Comm J Qual Saf (2004) 2.11

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data. Pharmacoepidemiol Drug Saf (2012) 2.11

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf (2007) 2.09

Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics (2004) 2.08

Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc (2004) 2.08

The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Circ Cardiovasc Qual Outcomes (2008) 2.03

Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine (2011) 2.03